Section
The latest stocks coverage from the TrustFinance editorial desk.
Shares of Swedish electronics equipment maker Mycronic soared after the company reported second-quarter results that decisively beat analyst estimates, driven by a record order intake and an upgraded full-year sales forecast.
The German biotech firm drastically cut its 2026 revenue and earnings forecasts, citing delayed milestone payments and slower deal-making, sending its stock to a near-decade low.
Subaru is recalling 541,237 vehicles in the United States because of an incorrect Gross Axle Weight Rating printed on the certification label, a safety issue flagged by federal regulators.
The South Korean tech giant is in early talks for a potential American Depositary Receipt offering, a move that comes after a record-setting US debut by rival SK Hynix, according to a Bloomberg report.
Shares of the Ray-Ban maker fell over 3% after Goldman Sachs cut its rating to 'Neutral,' citing moderating growth and intensifying competition in the smart eyewear market.
The German rail infrastructure company cut its full-year sales and earnings forecasts, citing weaker customer demand and project delays, triggering a sharp sell-off in its stock.
The Swedish online brokerage reported a significant earnings beat for the second quarter, citing stronger trading activity and a record influx of new customers amid improving investor sentiment.
Shares in the German medical and safety technology group rose after it reported preliminary Q2 sales that beat expectations and raised the lower end of its full-year profit margin forecast.
The British animal genetics firm boosted its full-year profit guidance, citing better-than-expected trading and robust performance in its key divisions, which significantly improved its cash position and reduced debt.
